• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病中形态学如何影响舒张功能?单中心经验。

How does morphology impact on diastolic function in hypertrophic cardiomyopathy? A single centre experience.

作者信息

Finocchiaro Gherardo, Haddad Francois, Pavlovic Aleksandra, Magavern Emma, Sinagra Gianfranco, Knowles Joshua W, Myers Jonathan, Ashley Euan A

机构信息

Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA Stanford Cardiovascular Institute, Stanford Cardiovascular Medicine, Stanford, California, USA.

出版信息

BMJ Open. 2014 Jun 12;4(6):e004814. doi: 10.1136/bmjopen-2014-004814.

DOI:10.1136/bmjopen-2014-004814
PMID:24928584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4067898/
Abstract

OBJECTIVES

It is unclear if morphology impacts on diastole in hypertrophic cardiomyopathy (HCM). We sought to determine the relationship between various parameters of diastolic function and morphology in a large HCM cohort.

SETTING

Tertiary referral centre from Stanford, California, USA.

PARTECIPANTS

383 patients with HCM and normal systolic function between 1999 and 2011. A group of 100 prospectively recruited age-matched and sex-matched healthy participants were used as controls.

PRIMARY AND SECONDARY OUTCOME MEASURES

Echocardiograms were assessed by two blinded board-certified cardiologists. HCM morphology was classified as described in the literature (reverse, sigmoid, symmetric, apical and undefined).

RESULTS

Reverse curvature morphology was most commonly observed (218 (57%). Lateral mitral annular E'<12 cm/s was present in 86% of reverse, 88% of sigmoid, 79% of symmetric, 86% of apical and 81% of undefined morphology, p=0.65. E/E' was similarly elevated (E/E': 12.3±7.9 in reverse curvature, 12.1±6.1 in sigmoid, 12.7±9.5 in symmetric, 9.4±4.0 in apical, 12.7±7.9 in undefined morphology, p=0.71) and indexed left atrial volume (LAVi)>40 mL/m(2) was present in 47% in reverse curvature, 33% in sigmoid, 32% in symmetric, 37% in apical and 32% in undefined, p=0.09. Each morphology showed altered parameters of diastolic function when compared with the control population. Left ventricular (LV) obstruction was independently associated with all three diastolic parameters considered, in particular with LAVi>40 mL/m(2) (OR 2.04 (95% CI 1.23 to 3.39), p=0.005), E/E'>15 (OR 4.66 (95% CI 2.51 to 8.64), p<0.001) and E'<8 (OR 2.55 (95% CI 1.42 to 4.53), p=0.001). Other correlates of diastolic dysfunction were age, LV wall thickness and moderate-to-severe mitral regurgitation.

CONCLUSIONS

In HCM, diastolic dysfunction is present to similar degrees independently from the morphological pattern. The main correlates of diastolic dysfunction are LV obstruction, age, degree of hypertrophy and degree of mitral regurgitation.

摘要

目的

目前尚不清楚肥厚型心肌病(HCM)的形态学是否会影响舒张功能。我们试图在一个大型HCM队列中确定舒张功能的各种参数与形态学之间的关系。

地点

美国加利福尼亚州斯坦福的三级转诊中心。

参与者

1999年至2011年间383例收缩功能正常的HCM患者。一组100名前瞻性招募的年龄和性别匹配的健康参与者作为对照。

主要和次要观察指标

由两名经过盲法评估的具备委员会认证的心脏病专家对超声心动图进行评估。HCM形态学按照文献中描述的进行分类(反曲型、乙状结肠型、对称型、心尖型和未定型)。

结果

最常观察到的是反曲型形态(218例(57%))。二尖瓣环外侧E'<12 cm/s在反曲型中占86%,乙状结肠型中占88%,对称型中占79%,心尖型中占86%,未定型中占81%,p = 0.65。E/E'同样升高(E/E':反曲型为12.3±7.9,乙状结肠型为12.1±6.1,对称型为12.7±9.5,心尖型为9.4±4.0,未定型为12.7±7.9,p = 0.71),且左心房容积指数(LAVi)>40 mL/m²在反曲型中占47%,乙状结肠型中占33%,对称型中占32%,心尖型中占37%,未定型中占32%,p = 0.09。与对照人群相比,每种形态学均显示舒张功能参数发生改变。左心室(LV)梗阻与所考虑的所有三个舒张参数均独立相关,特别是与LAVi>40 mL/m²(比值比2.04(95%置信区间1.23至3.39),p = 0.005)、E/E'>15(比值比4.66(95%置信区间2.51至8.64),p<0.001)和E'<8(比值比2.55(95%置信区间1.42至4.53),p = 0.001)相关。舒张功能障碍的其他相关因素包括年龄、LV壁厚度和中重度二尖瓣反流。

结论

在HCM中,舒张功能障碍在相似程度上独立于形态学模式存在。舒张功能障碍的主要相关因素是LV梗阻、年龄、肥厚程度和二尖瓣反流程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b14/4067898/347d2bf27590/bmjopen2014004814f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b14/4067898/99e8346773a5/bmjopen2014004814f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b14/4067898/fff591bdf15d/bmjopen2014004814f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b14/4067898/da6277238bfe/bmjopen2014004814f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b14/4067898/347d2bf27590/bmjopen2014004814f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b14/4067898/99e8346773a5/bmjopen2014004814f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b14/4067898/fff591bdf15d/bmjopen2014004814f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b14/4067898/da6277238bfe/bmjopen2014004814f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b14/4067898/347d2bf27590/bmjopen2014004814f04.jpg

相似文献

1
How does morphology impact on diastolic function in hypertrophic cardiomyopathy? A single centre experience.肥厚型心肌病中形态学如何影响舒张功能?单中心经验。
BMJ Open. 2014 Jun 12;4(6):e004814. doi: 10.1136/bmjopen-2014-004814.
2
Role of Doppler Diastolic Parameters in Differentiating Physiological Left Ventricular Hypertrophy from Hypertrophic Cardiomyopathy.多普勒舒张参数在鉴别生理性左室肥厚与肥厚型心肌病中的作用。
J Am Soc Echocardiogr. 2018 May;31(5):606-613.e1. doi: 10.1016/j.echo.2017.11.022. Epub 2018 Mar 1.
3
Prognostic significance of left ventricular end diastolic pressure using E/E' in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者中使用E/E'评估左心室舒张末期压力的预后意义
Echocardiography. 2019 Dec;36(12):2167-2175. doi: 10.1111/echo.14539. Epub 2019 Nov 19.
4
Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.肥厚型心肌病患者右心室插入点延迟钆增强的范围:与舒张功能障碍的关系
Eur Radiol. 2015 Apr;25(4):1190-200. doi: 10.1007/s00330-014-3390-8. Epub 2015 Jan 18.
5
Impaired myocardial function in hypertrophic cardiomyopathy.肥厚型心肌病中心肌功能受损。
Echocardiography. 2009 Jul;26(6):657-64. doi: 10.1111/j.1540-8175.2008.00871.x.
6
Influence of dynamic obstruction and hypertrophy location on diastolic function in hypertrophic cardiomyopathy.肥厚型心肌病中动态梗阻和心肌肥厚部位对舒张功能的影响。
J Cardiovasc Med (Hagerstown). 2014 Mar;15(3):207-13. doi: 10.2459/JCM.0b013e3283638093.
7
Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization.肥厚型心肌病患者经多普勒超声心动图评估左心室充盈压:与心导管检查时直接测量左心房压力的相关性
Circulation. 2007 Dec 4;116(23):2702-8. doi: 10.1161/CIRCULATIONAHA.107.698985. Epub 2007 Nov 19.
8
Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy.肥厚型心肌病中室间隔减容对左心房大小及舒张功能的影响
Echocardiography. 2016 May;33(5):686-94. doi: 10.1111/echo.13158. Epub 2016 Mar 1.
9
Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.使用实时三维超声心动图和二维斑点追踪成像评估肥厚型心肌病患者的左心室收缩和舒张异常。
Cardiovasc Ultrasound. 2018 Oct 2;16(1):23. doi: 10.1186/s12947-018-0142-y.
10
Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.左心室肥厚程度和分布作为肥厚型心肌病患者升高的利钠肽水平的决定因素:心脏磁共振成像的见解。
Int J Cardiovasc Imaging. 2012 Apr;28(4):763-72. doi: 10.1007/s10554-011-9876-4. Epub 2011 Apr 24.

引用本文的文献

1
Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathy.肥厚型心肌病患者肺动脉高压的患病率、性别差异及其影响
Front Cardiovasc Med. 2024 Jan 11;10:1288747. doi: 10.3389/fcvm.2023.1288747. eCollection 2023.
2
Role and Clinical Importance of Progressive Changes in Echocardiographic Parameters in Predicting Outcomes in Patients With Hypertrophic Cardiomyopathy.超声心动图参数的渐进性变化在预测肥厚型心肌病患者预后中的作用及临床重要性。
J Cardiovasc Imaging. 2023 Apr;31(2):85-95. doi: 10.4250/jcvi.2022.0053.
3
Cardiac Multimodality Imaging in Hypertrophic Cardiomyopathy: What to Look for and When to Image.

本文引用的文献

1
Hypertrophic cardiomyopathy: translating cellular cross talk into therapeutics.肥厚型心肌病:将细胞对话转化为治疗方法。
J Cell Biol. 2012 Oct 29;199(3):417-21. doi: 10.1083/jcb.201207033.
2
Hypertrophic cardiomyopathy.肥厚型心肌病。
Lancet. 2013 Jan 19;381(9862):242-55. doi: 10.1016/S0140-6736(12)60397-3. Epub 2012 Aug 6.
3
Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging.肥厚型心肌病的疾病进展模式:临床分期的个体化方法
肥厚型心肌病的心脏多模态影像学:需要观察什么以及何时进行成像。
Curr Cardiol Rev. 2023;19(5):1-18. doi: 10.2174/1573403X19666230316103117.
4
Association of NT-proBNP and hs-cTnT with Imaging Markers of Diastolic Dysfunction and Focal Myocardial Fibrosis in Hypertrophic Cardiomyopathy.NT-proBNP和hs-cTnT与肥厚型心肌病舒张功能障碍及局灶性心肌纤维化影像学标志物的关联
Life (Basel). 2022 Aug 16;12(8):1241. doi: 10.3390/life12081241.
5
The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review.马卡丹特对肥厚型心肌病病理生理学的影响:叙述性综述。
Am J Cardiovasc Drugs. 2022 Sep;22(5):497-510. doi: 10.1007/s40256-022-00532-x. Epub 2022 Apr 18.
6
Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.抑制心脏髓过氧化物酶可减轻肥厚型心肌细胞的舒张功能障碍。
Cardiovasc Res. 2022 Jan 29;118(2):517-530. doi: 10.1093/cvr/cvab077.
7
INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY.用于模拟肥厚型心肌病能量改变的诱导多能干细胞
Cond Med. 2019;2(4):142-151.
8
Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy.特发性左心室肥厚死者一级亲属中肥厚型心肌病的诊断率。
Europace. 2020 Apr 1;22(4):632-642. doi: 10.1093/europace/euaa012.
9
Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy.肥厚型心肌病不同表型的超声心动图诊断
Cardiovasc Ultrasound. 2016 Aug 12;14(1):30. doi: 10.1186/s12947-016-0072-5.
Circ Heart Fail. 2012 Jul 1;5(4):535-46. doi: 10.1161/CIRCHEARTFAILURE.112.967026.
4
Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.肥厚型心肌病中的疾病途径和新的治疗靶点。
Circ Res. 2011 Jun 24;109(1):86-96. doi: 10.1161/CIRCRESAHA.111.242974.
5
American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography.美国超声心动图学会关于肥厚型心肌病患者多模态心血管成像的临床建议:得到美国核心脏病学会、心血管磁共振学会和心血管计算机断层扫描学会认可。
J Am Soc Echocardiogr. 2011 May;24(5):473-98. doi: 10.1016/j.echo.2011.03.006.
6
Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy.遗传学与临床转归:改善肥厚型心肌病的治疗
Circulation. 2010 Dec 7;122(23):2430-40; discussion 2440. doi: 10.1161/CIRCULATIONAHA.110.978924.
7
Impact of left atrial volume on clinical outcome in organic mitral regurgitation.左心房容积对器质性二尖瓣反流临床结局的影响。
J Am Coll Cardiol. 2010 Aug 10;56(7):570-8. doi: 10.1016/j.jacc.2010.02.059.
8
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.成人右心超声心动图评估指南:美国超声心动图学会报告,得到欧洲心脏病学会注册分支欧洲超声心动图协会以及加拿大超声心动图学会认可。
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8. doi: 10.1016/j.echo.2010.05.010.
9
The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance.肥厚型心肌病左心室收缩和舒张功能障碍的进展:临床和预后意义。
J Cardiovasc Med (Hagerstown). 2010 Sep;11(9):669-77. doi: 10.2459/JCM.0b013e3283383355.
10
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy.肥厚型心肌病多普勒限制性充盈模式的预后意义。
Am J Cardiol. 2009 Dec 15;104(12):1727-31. doi: 10.1016/j.amjcard.2009.07.057.